Real-world study and prognostic analysis of angioimmunoblastic T-cell lymphoma
Currently, there is no consensus on the optimal initial therapy for AITL, and the efficacy of anthracycline-containing regimens remains suboptimal. The novel model developed herein demonstrates predictive significance for both OS and PFS, and exhibits better stratification and discrimination capabilities.
Authors
- Xiaoyan Feng (ORCID: https://orcid.org/0000-0002-5239-9362)
- Mengke Fan (ORCID: https://orcid.org/0000-0002-9194-5709)
- Qingjiang Chen
- Xiaolong Wu (ORCID: https://orcid.org/0000-0001-9059-0005)
- Jieming Zhang (ORCID: https://orcid.org/0000-0001-7262-4793)
- Lijuan Han (ORCID: https://orcid.org/0000-0003-1190-9634)
- Xudong Zhang
- Mingzhi Zhang (ORCID: https://orcid.org/0009-0008-5534-4042)
- Meng Dong (ORCID: https://orcid.org/0000-0002-6434-1678)
- Yunfei Song
- Suxiao Li (ORCID: https://orcid.org/0000-0003-4068-1560)
Institutions
- Henan Academy of Sciences (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- Henan Medical University (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-10-14
- DOI
- https://doi.org/10.3389/fimmu.2024.1481301
- Citations
- 2
- Primary Topic
- Vascular Tumors and Angiosarcomas
- Type
- article
- Field-Weighted Citation Impact
- 0.57